Fundraising Fox

Biotech Investors & VC Firms in Asia-Pacific

571 firms in this list, with a median first check of $650K. 110 of them lead rounds. Generated from verified public data and updated continuously.

Hongtai Capital Holdings
BeijingSeed–Late Stage
Starfish Ventures
MelbournePre-Seed–Growth$2M – $3.3M
2 people
Woori Technology Investment
Seoul
19 people
Miyako Capital
KyotoPre-Seed–Growth
5 people
Tin Alley Ventures
MelbournePre-Seed–Late Stage
14 people
Industrial Technology Investment Corporation
TaipeiSeed–Late Stage$1.9M – $227M
Merak Ventures
New DelhiPre-Seed–Series A$500K – $1.5M
7 people
GEOC
ShanghaiSeed–Late Stage$3M – $10M
11 people
Seiho Investment Works
KyotoPre-Seed–Growth$67K – $670K
7 people
BVCF
ShanghaiSeries A–Late Stage$5M
18 people
Bridgewest Ventures
AucklandPre-Seed–Seed
14 people
Decacorn Capital
SingaporeSeed–Series B$300K – $600K
13 people
NSG Ventures
SingaporeSeed–Series A
10 people
FundWA
Mount PleasantSeed–Series A
12 people
Kumpulan Modal Perdana
Petaling JayaSeed–Late Stage$380K – $1.5M
12 people
Daesung Private Equity
SeoulSeed–Late Stage
Breakthrough Victoria
MelbournePre-Seed–Late Stage
7 people
Hundreds Capital
BeijingSeed–Late Stage
3 people
TOHOKU University Venture Partners
SendaiPre-Seed–Growth
14 people
ORI Capital
Hong KongPre-Seed–Late Stage
15 people
Xeed Ventures
BengaluruPre-Seed–Series A$120K – $1.2M
7 people
T Capital Partners Co. Ltd.
TokyoGrowth–Late Stage$4B – $14B
3 people
Detong Capital
ShanghaiSeed–Late Stage$20M
11 people
Ideaspring Capital
BengaluruPre-Seed–Series A$2M
5 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.